cystinyl-aspartyl-prolyl-glycyl-tyrosyl-isoleucyl-glycyl-seryl-arginyl-nh2 has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, S; Dratz, EA; Starkey, JR | 1 |
| Dratz, EA; Helgerson, SL; Lambert, CG; Ostheimer, GJ; Starkey, JR | 1 |
2 other study(ies) available for cystinyl-aspartyl-prolyl-glycyl-tyrosyl-isoleucyl-glycyl-seryl-arginyl-nh2 and B16 Melanoma
| Article | Year |
|---|---|
Sidechain and backbone requirements for anti-invasive activity of laminin peptide 11.
Topics: Alanine; Animals; Basement Membrane; Drug Design; Female; Laminin; Lung Neoplasms; Magnetic Resonance Spectroscopy; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Models, Molecular; Neoplasm Invasiveness; Oligopeptides; Thermodynamics; Tumor Cells, Cultured | 1998 |
NMR constrained solution structures for laminin peptide 11. Analogs define structural requirements for inhibition of tumor cell invasion of basement membrane matrix.
Topics: Amino Acid Sequence; Animals; Basement Membrane; Dose-Response Relationship, Drug; Laminin; Magnetic Resonance Spectroscopy; Melanoma, Experimental; Mice; Models, Molecular; Molecular Sequence Data; Neoplasm Invasiveness; Oligopeptides; Protein Conformation; Tumor Cells, Cultured | 1992 |